-
Curcumin for monoclonal gammopathies. What can we hope for, what should we fear?
21 May 2012
A.J.M. Vermorken, J. Zhu, W.J.M. Van de Ven, E. Andrès
Abstract: Over the last decades there has been an increasing interest in a possible role of curcumin on cancer. Although curcumin is considered safe for healthy people, conclusive evidence on the safe...
-
Current issues in combined modality therapy in locally advanced head and neck cancer
17 May 2012
Anthony J. Cmelak
Abstract: Curative treatment for patients with locally advanced squamous cell carcinomas of the head and neck (SCCHN) is complex and multidisciplinary. Our understanding of the optimal management of t...
-
Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma
14 May 2012
Jose Manuel Vagace, Maria Dolores de la Maya, Cristina Caceres-Marzal, Silvia Gonzalez de Murillo, Guillermo Gervasini
Abstract: In the last decades, increasing success rates are being obtained in the chemotherapy of pediatric leukemia and lymphoma. However, the cornerstone of this treatment is still formed by a reduc...
-
Brain metastases from gastrointestinal tumours: Tailoring the approach to maximize the outcome
14 May 2012
Jessica Menis, Caterina Fontanella, Alessandro Follador, Gianpiero Fasola, Giuseppe Aprile
Abstract: Brain metastases from the gastrointestinal cancers (GI) are uncommon, but their incidence is constantly increasing due to several reasons, including improved systemic therapy and survival. N...
-
Angiogenesis: A promising therapeutic target for ovarian cancer
10 May 2012
A. Bamias, S. Pignata, E. Pujade-Lauraine
Abstract: Ovarian cancer is the leading cause of death from gynecological cancers. Primary treatment of advanced ovarian cancer (FIGO stages III and IV) until recently consisted of cytoreductive surge...
View More Articles in Press...
